CLIFF SLOOP: Open Payments
NPI 1548630452 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 99 payments from 20 companies in 2025. Trend: 2023 $1,656 · 2024 $1,801 · 2025 $1,621
Food & beverage: $1,584Education: $38
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $230 |
| AstraZeneca Pharmaceuticals LP | 10 | $172 |
| Lilly USA, LLC | 13 | $168 |
| Amgen Inc. | 14 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $148 |
| PFIZER INC. | 6 | $98 |
| Vanda Pharmaceuticals Inc. | 4 | $96 |
| Novo Nordisk Inc | 6 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Exact Sciences Corporation | 3 | $60 |
Products named: MOUNJARO, Kerendia, Repatha, NURTEC ODT, FANAPT, AIRSUPRA, QULIPTA, REXULTI.
Industry payments across AL — which companies pay providers there.
